Details of the Drug Reposition

General Information of This Drug (ID: DMV6DF3)

Drug Name	AZD5658 DMV6DF3

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)

2 Phase 1 Indication(s)

Indication Name	Indication ID	ICD-11	Status	REF
Diabetic complication	DIS4S2FC	5A2Y	Phase 1	[1]
Obesity	DIS47Y1K	5B81	Phase 1	[1]
------------------------------------------------------------------------------------

References

1	Clinical pipeline report, company report or official report of AstraZeneca (2011).